Navigation Links
Baxa Announces IntelliFlowRx(TM) to Become DoseEdge(TM) Dose Management System
Date:10/14/2009

ENGLEWOOD, Colo., Oct. 14 /PRNewswire/ -- Baxa Corporation announces the rebranding of its IntelliFlowRx Workload Management Software to DoseEdge. The name DoseEdge (pronounced "dosage") was chosen to reinforce the product's leading edge position in pharmacy dose management. DoseEdge streamlines the previously manual workflow for pharmacy doses through barcode drug verification; automatic dose calculation; image capture of dose creation and improving pharmacist checking activity.

"IntelliFlowRx was originally designed for IV room workflow management," notes Tim Kingsford, DoseEdge Product Manager. "With the launch of the new brand name DoseEdge, we are expanding the system's capabilities beyond the IV room for more complete dose management within the health-system pharmacy."

The DoseEdge brand launch supports Baxa Corporation's plan to continue product development - advancing the system's functional capabilities. The addition of Preparation Modes earlier this year allowed the system to filter and control the dose queue so that oral dose prep, extemporaneous compounding, tele-pharmacy and TPN manual additions can be tracked in addition to IV dose preparations. DoseEdge also was expanded to support TPN processing - allowing orders to be received from the Baxa Abacus(TM) Order Entry Software. Future DoseEdge upgrades will integrate the documentation and tracking system with Baxa equipment such as the ExactaMix(TM) Automated Compounders.

IntelliFlowRx was acquired by Baxa Corporation in March 2009 through its merger with ForHealth Technologies. The rebranding effort for IntelliFlowRx came from the understanding that the software had a broad application through pharmacy operations and the potential to be integrated with existing Baxa automation. This led to a desire for a product name that was memorable and easily accommodated future product line growth. Full transition from the current IntelliFlowRx brand to the
'/>"/>

SOURCE Baxa Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Sanofi Pasteur Announces Results of U.S. Clinical Trials of Influenza A (H1N1) Vaccine in Infants and Children
2. MedQuist Announces Reseller Agreement With Clario
3. Escalon(R) Announces Going Concern Qualification
4. Sangamo Announces Closing of Common Stock Offering
5. Catalyst Pharmaceutical Partners, Inc. Announces Organizational Changes and Extension of Chief Executives Employment Agreement
6. Eclipse Announces Partnership with Human Med USA, Manufacturers of Revolutionary Body-Jet(R)
7. Kendle Announces Details Regarding Third Quarter 2009 Earnings Conference Call and Webcast
8. ATS Medical Announces Receipt of CE Mark for the New ATS CryoMaze 10-S Probe
9. SAFC Pharma(R) Announces Completion of $12M Contract Manufacturing Facility Expansion in Carlsbad, Calif.
10. RSB Spine, LLC, Announces FDA Clearance for the InterPlate(R) C-Ti as an Anterior Cervical Plate
11. Sono-Tek Announces Second Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... -- According to Millennium Research Group (MRG), the ... the US minimally invasive spinal fusion market will ... over 12% through 2014, reimbursement concerns in certain ... which previously had been forecast at almost 20%. ... Spine Technologies 2010 report finds ...
(Date:12/16/2009)... Inc., a Johnson & Johnson (NYSE: ... surgical care, and Acclarent, Inc., a privately held ... commercializing devices that address conditions affecting the ear, ... merger agreement whereby Ethicon will acquire Acclarent in ... of estimated cash on hand at time of ...
(Date:12/16/2009)... at,deCODE genetics, Inc. (Nasdaq: DCGN ) publish in ... a common single-letter variant in the sequence of,the ... susceptibility to type 2,diabetes (T2D). The impact of ... unusual:,if an individual inherits it from their father, ... 30% compared to those who inherit the non ...
Breaking Medicine Technology:Reimbursement Difficulties With TranS1's AxiaLIF and NuVasive's XLIF Have Sceptics Talking 2Reimbursement Difficulties With TranS1's AxiaLIF and NuVasive's XLIF Have Sceptics Talking 3Ethicon Announces Definitive Agreement to Acquire Acclarent 2Ethicon Announces Definitive Agreement to Acquire Acclarent 3Ethicon Announces Definitive Agreement to Acquire Acclarent 4deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 2deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 3deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 4New Bone Building Drug Promising Against Prostate Cancer 54219 1New Bone Building Drug Promising Against Prostate Cancer 54219 2New Bone Building Drug Promising Against Prostate Cancer 54219 3Jefferson Headache Center study shows novel orally inhaled migraine therapy effective 54216 1Aging with GRACE 3A New health care delivery model improves outcomes saves money 54213 1Aging with GRACE 3A New health care delivery model improves outcomes saves money 54213 2Aging with GRACE 3A New health care delivery model improves outcomes saves money 54213 3
... Women with postmenopausal,osteoporosis receiving once-monthly Boniva(R) ... mineral density (BMD) to those,receiving once-weekly Fosamax(R) ... at the 29th Annual Meeting of the ... The study, called MOTION (Monthly Oral Therapy ...
... CHICAGO, Sept. 19 Targanta Therapeutics Corporation,today ... the in vitro,activity of its lead antibiotic ... against a variety of susceptible and resistant ... presented today at the 47th,Annual Interscience Conference ...
Other Medicine Technology:New Study Shows Once-Monthly Boniva(R) is as Clinically Effective as Once-Weekly Fosamax(R) at Increasing Bone Mineral Density in Postmenopausal Women With Osteoporosis 2New Study Shows Once-Monthly Boniva(R) is as Clinically Effective as Once-Weekly Fosamax(R) at Increasing Bone Mineral Density in Postmenopausal Women With Osteoporosis 3New Study Shows Once-Monthly Boniva(R) is as Clinically Effective as Once-Weekly Fosamax(R) at Increasing Bone Mineral Density in Postmenopausal Women With Osteoporosis 4Oritavancin Demonstrates Potent and Rapid In Vitro Activity Against MRSA, VRE and Other Strains of Resistant Bacteria 2Oritavancin Demonstrates Potent and Rapid In Vitro Activity Against MRSA, VRE and Other Strains of Resistant Bacteria 3Oritavancin Demonstrates Potent and Rapid In Vitro Activity Against MRSA, VRE and Other Strains of Resistant Bacteria 4Oritavancin Demonstrates Potent and Rapid In Vitro Activity Against MRSA, VRE and Other Strains of Resistant Bacteria 5
(Date:12/17/2009)... Deirdre Byrne to lead the firm’s Interim Leadership division as senior ... in healthcare consulting, Byrne will assume her duties at B. E. ... ... 2009 -- B. E. Smith recently hired Deirdre Byrne ... A seasoned executive with nearly 20 years of experience in healthcare ...
(Date:12/17/2009)... -- It,s customary for the holidays to wreak havoc ... of year, workouts often get short-changed and nutrition is ... trainer Valerie Waters, it is not impossible to enjoy ... why California Raisins and Waters have teamed up to ... the holiday season and get a jump start on ...
(Date:12/17/2009)... ( www.CareTech.com ), an information technology (IT) and web ... was named Best in KLAS, Extensive IT Outsourcing ... in KLAS Awards: Software & Professional Services report. ... in key market segments including EMRs, cardiology systems, IT ... performance score was 90.3 on a 100-point scale and ...
(Date:12/17/2009)... The recently opened Laser Spine ... the community in full force this holiday season, as ... 13th, benefiting the Arthritis Foundation, a non-profit organization dedicated ... event boasted 1,500 attendees, spotlighting LSI,s passion for their ... renowned, national fundraiser and a festive way to get ...
(Date:12/17/2009)... -- AlloSource, one of the nation,s largest non-profit providers ... in surgical procedures and the world,s largest processor of ... has been selected as a finalist in the 2010 ... Samaritan Institute category honoring non-profits. This is the second ... as a finalist by the annual awards program, now ...
Breaking Medicine News(10 mins):Health News:Deirdre Byrne Joins B. E. Smith as Senior Vice President, Interim Leadership Services 2Health News:Deirdre Byrne Joins B. E. Smith as Senior Vice President, Interim Leadership Services 3Health News:Celebrity Fitness Trainer Valerie Waters and California Raisins Offer Advice on How to Jump Start the New You in the New Year 2Health News:Celebrity Fitness Trainer Valerie Waters and California Raisins Offer Advice on How to Jump Start the New You in the New Year 3Health News:CareTech Solutions Named 2009 'Best in KLAS' for Extensive Information Technology Outsourcing for the Second Consecutive Year 2Health News:CareTech Solutions Named 2009 'Best in KLAS' for Extensive Information Technology Outsourcing for the Second Consecutive Year 3Health News:Laser Spine Institute (LSI) Supports Jingle Bell Run 2Health News:AlloSource Recognized for Exemplifying Ethics Amongst Colorado Non-Profits 2Health News:AlloSource Recognized for Exemplifying Ethics Amongst Colorado Non-Profits 3
... Nov. 3 Pregis Corporation, a leading,international ... and specialty packaging solutions, will conduct an ... quarter results on Friday,November 14, 2008 at ... 800-591-6942;,International: 617-614-4909; Participant Passcode: 68623125. A replay ...
... Orthopaedic osteoporosis management is a crucial element in ... Most patients who,suffer a hip fracture are referred ... However, according to a study published in the,November ... Joint Surgery,( http://www.ejbjs.org ), an osteoporosis management ...
... LifeNet Health,a leading allograft bio-implant company, ... United States Food and Drug Administration (FDA) ... technology., LifeNet Health received clearance for ... donor cells from cardiovascular tissues,while retaining the ...
... Nov. 3 BioMarin Pharmaceutical,Inc. (Nasdaq: BMRN ... Clinical,Assessment Program (MorCAP) for patients with the lysosomal ... A Syndrome. MorCAP is,designed to augment available data ... and other parameters in affected patients.,BioMarin expects to ...
... GeneThera, Inc.,(Pink Sheets: GTHR), As a service and responsibility ... the future of the company.,GeneThera is making a pivotal ... marketing and revenue generating entity., The company strategy ... (July, 2008) had been one of research only. We ...
... Ala., Nov. 3 BioCryst,Pharmaceuticals, Inc. (Nasdaq: BCRX ... Executive Officer of BioCryst, will present,a corporate update at ... York on Monday, November 10, 2008 at 9:55 a.m. ... at the Palace Hotel,in New York, New York., ...
Other Medicine News:Health News:Treating Osteoporosis After Hip Fracture 2Health News:Treating Osteoporosis After Hip Fracture 3Health News:BioMarin Announces Initiation of Clinical Assessment Program for Morquio A Syndrome 2Health News:BioMarin Announces Initiation of Clinical Assessment Program for Morquio A Syndrome 3Health News:BioMarin Announces Initiation of Clinical Assessment Program for Morquio A Syndrome 4Health News:GeneThera - CHANGING DIRECTIONS - an Update to Shareholders 2Health News:GeneThera - CHANGING DIRECTIONS - an Update to Shareholders 3Health News:GeneThera - CHANGING DIRECTIONS - an Update to Shareholders 4Health News:GeneThera - CHANGING DIRECTIONS - an Update to Shareholders 5Health News:GeneThera - CHANGING DIRECTIONS - an Update to Shareholders 6Health News:BioCryst to Present at the Rodman and Renshaw 10th Annual Healthcare Conference 2Health News:BioCryst to Present at the Rodman and Renshaw 10th Annual Healthcare Conference 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: